Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results as an Analgesic in Animal Models of Neuropathic and Visceral Pain

GlobeNewswire November 14, 2016

Biotech Stocks Under Scanner -- Anavex Life Sciences, Eleven Biotherapeutics, Achillion Pharma, and Tokai Pharma

PR Newswire November 11, 2016

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  October 5, 2016

Anavex Life Sciences and Ariana Pharma Collaborate to Accelerate Timelines and Improve Efficiency of Alzheimer’s and Parkinson’s Clinical Development Programs

GlobeNewswire October 5, 2016

Mid-Afternoon Market Update: Dow Gains 80 Points; Crude Oil Up 5%

Benzinga.com  September 28, 2016

Anavex Life Sciences Shares Experimenting With 2-Month Highs

Benzinga.com  September 28, 2016

Mid-Day Market Update: U.S. Stocks Turn Lower; Anavex Shares Spike Higher

Benzinga.com  September 28, 2016

Mid-Morning Market Update: Markets Open Higher; BlackBerry Earnings Beat Estimates

Benzinga.com  September 28, 2016

18 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  September 28, 2016

Anavex Compound to be Tested in Biogen Neurological Protection Model

GlobeNewswire September 28, 2016

15 Biggest Mid-Day Gainers For Thursday

Benzinga.com  September 22, 2016

Anavex Life Sciences’ Drug Shows Efficacy to Support Potential Disease Modification in Parkinson’s Disease

GlobeNewswire September 22, 2016

Anavex to Present at Ladenburg Thalmann 2016 Healthcare Conference

GlobeNewswire September 20, 2016

Anavex to Participate in Mizuho Therapeutics Conference

GlobeNewswire September 14, 2016

12 Biggest Mid-Day Losers For Tuesday

Benzinga.com  September 13, 2016

Technical Roundup on Biotech Stocks -- Anavex Life Sciences, Threshold Pharma, StemCells, and Aratana Therapeutics

PR Newswire August 17, 2016

Anavex Reports Fiscal Third Quarter 2016 Financial Results

GlobeNewswire August 11, 2016

Anavex Confirms Phase 2a Trial Data Of ANAVEX 2-73 In Alzheimer's Patients Presented At AAIC

Benzinga.com  July 29, 2016

Anavex Confirms Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients Presented at AAIC 2016

GlobeNewswire July 29, 2016

Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016

GlobeNewswire July 27, 2016